Buda Juice, which makes branded and private label citrus drinks, announced terms for its IPO on Monday.
The Dallas, TX-based company plans to raise $22 million by offering 2.7 million shares (25% secondary) at a price range of $7.50 to $9.00. At the midpoint of the proposed range, Buda Juice would command a market cap of $99 million.
Buda Juice states that it is pioneering the "UltraFresh" juice category through its end-to-end cold chain platform. Its product portfolio consists of fresh citrus juices and wellness shots across multiple brand lines and retail customers, which it believes demonstrates both brand diversification and private label manufacturing capabilities. The company currently operates from its Dallas plant but has plans for facilities in South Carolina (2026) and Arizona/Nevada (2027).
Buda Juice was founded in 2013 and booked $12 million in revenue for the 12 months ended June 30, 2025. It plans to list on the NYSE under the symbol BUDA. MDB Capital Group is the sole bookrunner on the deal.
